Author
@Merck Merck
Official Merck corporate account broadcasting its own pipeline, regulatory, and earnings milestones
Publish first-party corporate communications — clinical tria
trader score
+0.47
hit rate
40%
mean α
+5.12%
signals 14d
2
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 5 scored bets: 40% hit rate, +5.12% mean alpha, trader score +0.47. Their last-14d mentions, direction-adjusted, have moved -11.7% since posting (mean over 2 mentions with price data).
Recent signals2receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-19 | MRK | @Merck | +0.55 | Merck reports positive Phase 3 results for its individualized therapy collaboration with Moderna. | -2.5% | tweet ↗ |
| 2026-08-19 | MRNA | @Merck | +0.55 | Merck reports positive Phase 3 results for its individualized therapy collaboration with Moderna. | -20.9% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.